Cancer treatment decisions are rarely one-size-fits-all — and age can change what “the right treatment” actually looks like. A 70-year-old and a 40-year-old with the same diagnosis may need very different treatment plans, based on their overall health, other conditions, and personal priorities.
In September 2026, the National Comprehensive Cancer Network (NCCN) — a leading alliance of cancer centers — released a new set of guidelines specifically built around this idea: helping older adults and their families understand what to ask for, and expect, during cancer care.
This article breaks down what’s new, in plain language, and what it could mean for older patients and their caregivers.
- NCCN published two versions of the new guideline: a clinical version for doctors (released 4 September 2026) and a patient-and-caregiver version (released 16–17 September 2026)
- The central idea is that a cancer diagnosis alone doesn’t tell a doctor enough about how well an older patient will tolerate treatment — a structured evaluation is needed
- The guidelines were developed by an international task force, co-led by Dr. Louise Walter of UCSF
- They’re aimed primarily at patients over 65, though the guidance may be relevant to younger patients with significant additional health concerns
What Is a Geriatric Assessment, and Why Does It Matter?
- A geriatric assessment is a structured evaluation that looks beyond the cancer itself — checking memory and cognition, physical strength and mobility, other existing health conditions, nutrition, social support, and current medications
- According to the guidelines, this assessment matters because a patient’s ability to physically tolerate chemotherapy, radiation, or surgery can vary enormously between two people of the same age
- The assessment can also flag risks that are easy to miss in a standard oncology visit — such as a higher fall risk, medication interactions, or early signs of cognitive difficulty
- Identifying these issues early allows the care team to adjust the treatment plan, add support services, or address a reversible problem (like poor nutrition) before starting treatment
What Researchers and Doctors Are Saying
- Dr. Efrat Dotan, one of the guideline developers, emphasized that every patient over 65 with cancer should be carefully assessed, since there can be a wide range in memory function, physical ability, and how a person’s other medications might interact with cancer treatment
- The guideline authors have stressed that the goal isn’t to limit treatment for older patients — it’s to make sure the treatment plan is genuinely matched to what that individual can safely handle
- The patient-facing guide is also meant to help patients and families have more informed, structured conversations with their oncology team, rather than relying only on general questions
What This Means for Patients
- This is now official, published guidance — not early-stage research. It’s meant to directly shape how oncology teams evaluate and plan treatment for older patients going forward
- Patients and caregivers can now access a dedicated resource explaining, in plain language, what a geriatric assessment involves and why it’s being recommended
- Good to know:
- A geriatric assessment does not mean a doctor thinks less treatment is appropriate — it’s a tool to personalize the treatment plan, which can sometimes mean more support, not less treatment
- Not every cancer center may have formally adopted a structured geriatric assessment process yet — patients may need to specifically ask whether one is available
- These guidelines are most relevant for patients 65 and older, but the underlying principle — assessing overall health, not just age, before deciding on treatment — can be relevant to younger patients with multiple health conditions too
When to Speak With a Specialist
It’s worth raising a geriatric assessment directly with your oncology team if:
- You or a family member is 65 or older and has recently been diagnosed with cancer
- You’re unsure whether age or other health conditions have been factored into the proposed treatment plan
- You want to better understand the risks and benefits of a specific treatment given your overall health, not just the cancer diagnosis
- You’re a caregiver trying to prepare better questions for an upcoming oncology appointment
- You’re considering a second opinion and want a more complete picture of what treatment options may be appropriate
Understanding your full treatment options — and how they account for your overall health, not just your diagnosis — is easier with guidance from a qualified specialist. Getting connected with the right oncologist and support network can help ensure a cancer treatment plan is genuinely built around your specific situation, rather than a generic approach.
Future Research and Next Steps
- Researchers continue to study which specific assessment tools work best in different cancer types and treatment settings
- Ongoing trials are examining whether structured geriatric assessments actually reduce treatment-related complications and improve quality of life, not just survival outcomes
- Wider adoption of these assessments across more cancer centers — including outside major academic hospitals — is likely to remain a focus in the coming years
Conclusion
The new NCCN guidelines don’t introduce a new cancer treatment — they introduce a better way of deciding which treatment fits an individual older patient. For patients and families, the most useful takeaway is simple: age alone shouldn’t decide a treatment plan, and it’s reasonable to ask your oncology team whether a geriatric assessment has been, or could be, done as part of your care.
Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider about your specific treatment options.
Frequently Asked Questions (FAQs)
Released in September 2026, it's a set of clinical and patient-facing guidelines explaining how a structured "geriatric assessment" — evaluating physical function, cognition, nutrition, and other health conditions — should guide cancer treatment decisions for patients over 65.
It's a structured evaluation that looks at an older patient's overall health beyond the cancer diagnosis, including memory, mobility, nutrition, other medical conditions, and current medications, to help doctors personalize the treatment plan.
Not necessarily. The purpose is to match treatment to what a patient can safely tolerate — which can mean added support alongside standard treatment, not automatically less treatment.
Patients aged 65 and older who have been diagnosed with cancer, and their caregivers, are the primary audience — though the underlying approach may be relevant for younger patients with significant additional health conditions.
They are official, published clinical guidelines from NCCN, meant for immediate use by oncology teams — not experimental or early-stage research.
Original Research Source
This article is based on findings from newly published clinical guidelines and related coverage.
Primary Source: NCCN Clinical Practice Guidelines in Oncology — Older Adult Oncology (released 4 September 2026); NCCN Guidelines for Patients — Older Adults with Cancer (released 16–17 September 2026)
Media Coverage: UCSF News — Two New Guides Released to Help Older Patients with Cancer
The content has been independently rewritten, analyzed, and simplified for educational purposes to help patients and families better understand this guidance.
